Latest news with #ArtemPodrez
Yahoo
27-05-2025
- Business
- Yahoo
Citi Cuts Peloton (PTON) Price Target, Reiterates Neutral Rating
On May 27, Citi analyst Ronald Josey cut Peloton Interactive, Inc.'s (NASDAQ:PTON) price target to $8.50 from $10 and maintained a Neutral rating on the stock. The adjustment comes on the exercise equipment company delivering mixed third-quarter fiscal 2025 results. While sales fell 13.1% year-over-year to $624 million, they beat analysts' estimates of $621.5 million. The company posted adjusted earnings of $89.4 million, better than the expected $80.37 million. A woman reading and analyzing stock market data. Photo by Artem Podrez on Pexels Josey's Neutral stance also comes on Peloton lifting its revenue guidance for the year to $2.46 billion. The new revenue guidance reflects the expectation of favorable subscription revenue driven by higher paid connected fitness subscription management. It also expects EBITDA of $340 million, below analyst estimates of $345 million, as the free cash flow margin is expected to improve to 15.2% from 1.2% last year. Citi also remains optimistic about Peloton's prospects on churn rates declining by 0.2% to 1.2%. The improvement comes from customers reacting positively to new product offerings such as Strength modalities. In addition, the company is benefiting from the new CEO's strategic objective, which focuses on accelerating growth and cutting costs. Peloton remains focused on acquiring new members cost-effectively, as depicted by advertising and marketing spending decreasing 46% year-over-year in fiscal Q3. The company expects Ending Paid Connected Fitness Subscriptions to range between 2.77 and 2.79 million in FY25, reflecting a ten thousand increase at the midpoint. Peloton Interactive, Inc. provides Members with world-class equipment, ground-breaking software, expert human instruction, and the world's most supportive fitness community. It offers connected fitness products, including Peloton Bike, Peloton Bike+, Peloton Tread, Peloton Tread+, Peloton Guide, and Peloton Row names through e-commerce and inside sales, retail showrooms. While we acknowledge the potential of Peloton Interactive, Inc. (NASDAQ:PTON) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PTON and that has 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23-05-2025
- Business
- Yahoo
L3Harris Technologies Tapped for $175B Golden Dome System
L3Harris Technologies, Inc. (NYSE:LHX) rallied by as much as 4% on May 21 as President Donald Trump's administration announced plans to build the Golden Dome missile defense system that leverages its satellites. The $175 billion defense system is slated for completion in less than three years. The aerospace and defense company has carved a niche in developing mission-critical solutions for governments and commercial customers. Consequently, it is well-positioned to be one of the biggest beneficiaries of the development of the Golden Dome System amid calls for more homegrown products and systems. The latest deal comes as the company is completing a $125 million expansion at Fort Wayne. A woman reading and analyzing stock market data. Photo by Artem Podrez on Pexels Additionally, L3Harris Technologies has already inked a $214 million order deal under Germany's Digitalization Land-Based program. The program is for the delivery of interoperable communication systems to enhance the capabilities of the German armed forces. Amid the wave of deals, JPMorgan has reiterated an Overweight rating on the stock with a $255 price target. The bullish stance stems from the company's involvement in significant defense programs expected to bolster its revenue base. With an annual revenue base of about $21 billion, L3Harris has rewarded investors with dividends for 55 years. While we acknowledge the potential of L3Harris Technologies, Inc. (NYSE:LHX) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LHX and that has 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. Sign in to access your portfolio
IOL News
15-05-2025
- Health
- IOL News
Understanding Type 5 Diabetes: A landmark recognition in global health
Diabetes is a chronic condition that affects how your body processes blood sugar. Image: Artem Podrez / Pexels In a landmark announcement at the International Diabetes Federation (IDF) World Diabetes Congress 2025 in Bangkok, Thailand, a new category of diabetes, Type 5 Diabetes, was formally recognised by global health experts. This classification represents a long-overdue acknowledgement of a form of diabetes that affects millions but has remained underdiagnosed and misclassified for decades. 'The recognition of Type 5 diabetes marks a historic shift in how we approach diabetes globally. This is about equity, science, and saving lives,' says Professor Peter Schwarz, President of the IDF. What is type 5 diabetes? Type 5 diabetes, also known as malnutrition-related diabetes, is a newly classified form of diabetes driven primarily by chronic undernutrition, especially during the formative years of childhood and adolescence. The condition leads to impaired development of the pancreas, resulting in severe insulin deficiency. Unlike other types of diabetes, however, this form is not caused by autoimmunity, as in Type 1, or insulin resistance, as in Type 2. Who is affected? Type 5 diabetes is estimated to impact 20–25 million people worldwide, particularly in low- and middle-income countries (LMICs) across Asia and Africa. Those affected are often teens and young adults, lean or underweight individuals and those living in resource-limited settings. Because of its unique characteristics, it has often been misclassified as either Type 1 or Type 2 diabetes in clinical settings, leading to inappropriate treatment strategies. A major focus of the new IDF Working Group on Type 5 Diabetes, led by Dr. Meredith Hawkins (Albert Einstein College of Medicine, USA) and Dr. Nihal Thomas (Christian Medical College, India), is to: Develop formal diagnostic criteria Establish a global patient registry Create educational materials for health workers in LMICs Explore cost-effective therapies Here's a breakdown of all types of diabetes Type 1 diabetes Cause: Autoimmune destruction of insulin-producing beta cells Onset: Typically in children and young adults Insulin resistance: Absent Treatment: Lifelong insulin therapy Prevalence: 5–10% of all diabetes cases Type 2 diabetes Cause: Insulin resistance and eventual insulin production decline Onset: Usually adulthood, but increasingly seen in youth Risk factors: Obesity, sedentary lifestyle, genetics Treatment: Diet, exercise, oral meds, sometimes insulin Prevalence: ~90% of all diabetes cases Gestational diabetes Cause: Hormonal changes during pregnancy leading to insulin resistance Onset: During pregnancy Risk: Increased future risk of Type 2 diabetes for both mother and child Treatment: Diet, exercise, insulin if needed Monogenic diabetes Cause: Single gene mutations affecting insulin production Onset: Often in childhood or young adulthood Treatment: Varies because some forms are responsive to sulfonylureas Type 3c diabetes Cause: Damage to the pancreas (e.g., pancreatitis, cancer, surgery) Onset: Variable, depending on pancreatic disease Treatment: Insulin and enzyme replacement Type 5 diabetes (new) Cause: Chronic malnutrition impairs pancreatic development Onset: Teens and young adults, especially in LMICs Insulin resistance: Low Treatment: Often oral medications; tailored to resource availability Prevalence: 20–25 million globally (mostly unrecognised) The recognition of Type 5 Diabetes is more than just a medical milestone, it is a step toward health equity for the millions of people in developing regions who have lacked proper diagnosis and care. The evolution of diabetes classification reflects the growing understanding that diabetes is not a one-size-fits-all disease. With Type 5 diabetes now formally recognised, global healthcare systems have an opportunity, and a responsibility, to adapt diabetes care to diverse populations and unique socioeconomic contexts. IOL Lifestyle
